• Ishwar Ramesh Kawde
• Rahul Mohan
• Dr Rajendra kawade
• Kiran kurhade

Chronic liver damage leads to the development of regenerative nodules within the liver parenchyma, surrounded by fibrous septa, indicative of cirrhosis. The progression involves liver cell necrosis, subsequent fibrosis, and the formation of nodules. This process results in cirrhosis, causing aberrant liver anatomy that hinders blood flow and hepatocyte function, leading to portal hypertension. Chronic liver diseases, including cirrhosis, pose a significant global health challenge. The wide-ranging clinical manifestations of cirrhosis, from asymptomatic to full hepatic decompensation, contribute to the challenge of accurately determining its prevalence worldwide. Diagnosis relies on various radiological techniques, including magnetic resonance imaging, computerized tomography scans, transient elastography, histological tests, and serological testing. Ursodeoxycholic acid is a common treatment for primary biliary cirrhosis.

Liver disease, Hepatic cirrhosis,Fibrosis, Hepatitis, Alcohol abuse,Portal hypertension,Ascites,Jaundice, Liver transplant,Hepatocellular carcinoma

"Liver Cirrhosis: Epidemiology, Pathophysiology, Symptoms and complications.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.d224-d229, November-2023, Available :http://www.jetir.org/papers/JETIR2311327.pdf

"Liver Cirrhosis: Epidemiology, Pathophysiology, Symptoms and complications.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppd224-d229, November-2023, Available at : http://www.jetir.org/papers/JETIR2311327.pdf